0001142750
false
0001142750
2020-04-03
2020-04-03
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of
report (Date of earliest event reported): April 3, 2020
AMN HEALTHCARE SERVICES, INC. |
(Exact name of registrant as specified in its charter) |
Delaware |
001-16753 |
06-1500476 |
(State or other jurisdiction
of incorporation) |
(Commission
File Number) |
(I.R.S. Employer
Identification No.) |
8840 Cypress Waters Boulevard, Suite 300
Dallas, Texas 75019 |
(Address of principal executive offices) (Zip Code) |
|
(866) 871-8519 |
(Registrant’s Telephone Number, Including Area Code) |
|
NOT APPLICABLE |
(Former Name or Former Address, if Changed Since Last Report) |
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2. below):
|
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
|
|
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
|
|
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
|
|
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange
on
which registered |
Common Stock, par value $0.001 per share |
|
AMN |
|
NYSE |
Indicate by check mark whether the
registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2
of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01.
Other Events.
On
April 3, 2020, AMN Healthcare Services, Inc. (the “Company”) issued a press release announcing that, due to public
health concerns relating to the novel coronavirus (COVID-19) pandemic, the location of the Company’s 2020 Annual Meeting
of Shareholders has been changed and will be held virtually. A copy of the press release is attached hereto as Exhibit 99.1
and is incorporated herein by reference.
Item 9.01. Financial Statements
and Exhibits.
(d) Exhibits
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
AMN Healthcare Services, Inc. |
|
|
|
|
|
Date: April 3, 2020 |
By: |
/s/ Susan R. Salka |
|
|
|
Susan R. Salka |
|
|
|
President & Chief Executive Officer |
|
EXHIBIT 99.1
AMN Healthcare to Hold Virtual 2020 Annual Meeting of Shareholders
DALLAS and SAN DIEGO, April 3, 2020 /PRNewswire/ -- AMN Healthcare Services, Inc. (NYSE: AMN) today announced that, due to public health
concerns relating to the novel coronavirus (COVID-19) pandemic, and to protect the health and well-being of its shareholders, directors and employees, AMN’s 2020 Annual Meeting of Shareholders (the “Annual Meeting”) will now be held virtually at 8:30
a.m. Central Time on April 22, 2020. The virtual meeting will provide shareholders the ability to participate, vote their shares, and ask questions during the meeting.
As described in the proxy materials for the Annual Meeting previously distributed, shareholders are entitled to participate in the
Annual Meeting if they were a shareholder as of the close of business on February 24, 2020, the record date, or hold a legal proxy for the meeting provided by their bank, broker, or nominee. To be virtually admitted to the Annual Meeting, go to www.virtualshareholdermeeting.com/AMN2020 and enter your 16-digit control number that is provided on the notice you previously received. You may
vote during the Annual Meeting by following the instructions available on the meeting website during the meeting. Regardless of whether you plan to attend the Annual Meeting, we urge you to vote and submit your proxy in advance of the meeting by one
of the methods described in the proxy materials for the Annual Meeting. The proxy card included with the proxy materials previously distributed may continue to be used to vote your shares in connection with the Annual Meeting. The proxy statement
and Annual Report are available on our Investor Relations website at http://www.amnhealthcare.investorroom.com.
AMN Healthcare is the leader and innovator in total talent solutions for healthcare organizations across the nation. The Company provides access to the most comprehensive network of quality healthcare professionals through its innovative
recruitment strategies and breadth of career opportunities. With insights and expertise, AMN Healthcare helps providers optimize their workforce to successfully reduce complexity, increase efficiency and improve patient outcomes. AMN total talent
solutions include managed services programs, clinical and interim healthcare leaders, temporary staffing, executive search solutions, vendor management systems, recruitment process outsourcing, predictive modeling, language interpretation services,
revenue cycle solutions, credentialing and other services. Clients include acute-care hospitals, community health centers and clinics, physician practice groups, retail and urgent care centers, home health facilities, schools and many other
healthcare settings. AMN Healthcare is committed to fostering and maintaining a diverse team that reflects the communities we serve. Our commitment to the inclusion of many different backgrounds, experiences and perspectives enables our innovation
and leadership in the healthcare services industry. For more information about AMN Healthcare, visit www.amnhealthcare.com.
Contact:
Randle Reece
AMN Healthcare
Director, Investor Relations
866.861.3229
investorrelations@amnhealthcare.com